DnXT Reviewer — Interactive Platform Demo

Application	Type	Region	Status
Keytruda	BLA	US FDA	Active
Ozempic	NDA	ICH	Under Review
Dupixent	IND	Health Canada	Approved
Humira Biosimilar	ANDA	US FDA	Draft
Entresto	NDA	GCC	Submitted

Metric	This Month	Last Month	Change
Submissions Published	28	22	+27%
Documents Reviewed	347	289	+20%
Avg Review Time	2.1 days	2.8 days	-25%
Validation Pass Rate	96.3%	94.1%	+2.2%
First-Time Acceptance	98.5%	97.8%	+0.7%

To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.

Functional Always active

The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.

Preferences

The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.

Statistics

The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.

Marketing

The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.

DnXT Reviewer — Interactive Platform Demo

Good afternoon, Jennifer!

Dossier Library

Global Search

Import Dossier

Importing Dupixent-IND-0015

Reports & Analytics

See DnXT Reviewer in Action